Why patients respond to a life-saving melanoma drug
Wednesday, November 26, 2014 - 15:30
in Health & Medicine
Researchers have pioneered a new methodology to predict why some patients battling advanced melanoma respond well or not at all to the new breakthrough drug pembrolizumab (Keytruda).